DNA-encoded library technology expert HitGen just inked a multiyear, multitarget drug discovery deal with Aduro Biotech.

Charles River Laboratories is buying CRO Brains On-Line for €18 million as it further strengthens its offers in CNS early-stage drug research.

WIRB-Copernicus Group has bought Patient Genesis’ eConsent technology, ConsentNow.

PRA will buy health data and analytics expert Symphony Health for $530 million up front as it reports 16% second-quarter service revenue growth.

German CRO Evotec is acquiring U.S. counterpart Aptuit in a $300 million deal.

Sarepta offers Exondys 51 outside of the U.S. through a managed access program run by Clinigen, as an EMA decision is expected next year.

Private equity firm EQT is acquiring Certara from Arsenal Capital Partners, a deal that values the CRO at $850 million, Arsenal announced on Tuesday.

Neuroscience-focused digital technology company Ixico just nabbed a contract for imaging clinical trial services from Spanish biotech Araclon.

INC says it is focused on growing its Asia presence with moves and an expansion.

Deals